1. Home
  2. MLSS vs INTS Comparison

MLSS vs INTS Comparison

Compare MLSS & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.28

Market Cap

22.9M

Sector

Health Care

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.40

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLSS
INTS
Founded
1989
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
24.0M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
MLSS
INTS
Price
$0.28
$0.40
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$1.00
$4.33
AVG Volume (30 Days)
298.5K
3.1M
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,929,517.00
N/A
Revenue This Year
$8.95
N/A
Revenue Next Year
$7.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.59
N/A
52 Week Low
$0.28
$0.19
52 Week High
$1.39
$3.17

Technical Indicators

Market Signals
Indicator
MLSS
INTS
Relative Strength Index (RSI) 36.53 45.52
Support Level $0.28 $0.37
Resistance Level $0.32 $0.43
Average True Range (ATR) 0.04 0.05
MACD -0.00 -0.01
Stochastic Oscillator 12.10 13.19

Price Performance

Historical Comparison
MLSS
INTS

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: